Loading…
5 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2023 |
|---|---|
| Revenue | 102,059 |
| EBITDA | 16,365 |
| Net profit | 16,036 |
| Total assets | 64,864 |
| n (companies reporting) | 5 |
GEL, thousands
| Company | FY 2023 |
|---|---|
| Inparm | 23,148 |
| New Georgia - 555 | 22,814 |
| Denk Pharma Caucasus | 20,487 |
| Megaveti | 11,860 |
| Sama Holding | 23,750 |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.